New Delhi: Dr Reddy’s Laboratories (DRL) has received final approval for its Abbreviated New Drug Application (ANDA) for Ranitidine 150mg pill by the US Food and Drug Administration (FDA)
DRL is the only generic maker to get FDA authorization for this Abbreviated New Drug Application (ANDA) product accompanying the expiry of innovator's patents.
According to a statement, the company will distribute the 150 mg potency in blister counts of 8 and 24’s plus bottles of 50, 65 and 95 counts.
Washington: Researchers at the Massachusetts Institute of Technology (MIT) say that they have identified the gene responsible for binocular vision, which may lead to new treatments for sensory disorders in which people experience the strange phenomena of seeing better with one eye covered.
Unlike horses and eagles, whose eyes on the sides of their heads provide two different scenes, humans see a single, in-depth view.
Washington, Sep 14 (ANI): Researchers have discovered a new application for tropical and popular aquarium fish, Zebrafish – it can now be used to study COX deficiencies in humans.
Researchers at the University of Oregon claim that their finding has opened an unparalleled pathway to examine the earliest stages of mitochondrial impairments that lead to potentially fatal metabolic disorders.
Washington, Sept 14: Non-stick chewing gum is all set to be a reality soon, for a company has completed developing new Clean Gum that can be easily removed from shoes, clothes, pavements and hair.
Revolymer, a spin out company from the University of Bristol, has completed initial street trials on pavements in local high streets as a part of a collaborative agreement with local councils.
Washington, Sept 13 (ANI): Surgeons at the University of California, San Diego Medical Center have removed a patient’s gallbladder through the vagina.
The clinical trial was conducted to assess the safety and effectiveness of performing abdominal procedures through the body’s natural openings to eliminate scarring.